UK’s Sterling Pharma Solutions buys Cary’s CiVentiChem

Sterling said it bought CiVentiChem to offer better access to its U.S. clients and enhance its chemistry development capabilities to support pre-clinical and early-phase clinical supply. The companies did not disclose financial terms.

Read More